Japan Times
Clinical trials for Alzheimer’s treatment face global shortage of participants
The shortage of trial participants risks slowing progress in dementia therapies, Alzheimer's Disease International warns.
View original source — Japan Times ↗
Related stories
The Guardian
HealthSep 5, 2026 · 1 min
Alzheimer’s trial to test drug on people without symptoms to see if it can be prevented
The Guardian
RNZ
HealthSep 20, 2026 · 1 min
Alzheimer's disease starting to be considered a treatable condition - study
RNZ
ABC News
WorldSep 20, 2026 · 1 min
Australians waiting years for dementia diagnoses, landmark survey finds
ABC News
BBC
PoliticsSep 17, 2026 · 1 min
Andy Burnham urged to set dementia waiting-time target
BBC